![Axel Bouchon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Axel Bouchon
Gründer bei
BrainLuxury, Inc.
Profil
Dr. Axel Bouchon is a Venture Partner at ARCH Venture Partners LLC, a Chairman at Brain Games Corp., a Chairman at BrainLuxury, Inc., a Chief Executive Officer at Matter Neuroscience, Inc. and a Chief Executive Officer at AMLOne UG (haftungsbeschränkt).
Dr. Bouchon was previously employed as a Non-Executive Director by Brii Biosciences Ltd. (China), a Head-Lifescience Center by Bayer AG, a Member by Moderna, Inc., and a Chief Executive Officer by Moderne Capital LLC.
He received his doctorate degree from Eberhard Karls Universität Tübingen.
Aktive Positionen von Axel Bouchon
| Unternehmen | Position | Beginn |
|---|---|---|
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01.12.2021 |
BrainLuxury, Inc.
 BrainLuxury, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures and commercializes nutritional brain supplements products | Gründer | 01.01.2020 |
Brain Games Corp.
 Brain Games Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in neuroscience and tech to help people track and boost their happiness | Vorsitzender | 01.01.2020 |
AMLOne UG (haftungsbeschränkt) | Vorstandsvorsitzender | 01.07.2016 |
Matter Neuroscience
 Matter Neuroscience Packaged SoftwareTechnology Services Develops mobile application for neurological reward systems | Vorstandsvorsitzender | 01.01.2019 |
Ehemalige bekannte Positionen von Axel Bouchon
| Unternehmen | Position | Ende |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Direktor/Vorstandsmitglied | 30.09.2022 |
| BAYER AG | Corporate Officer/Principal | 01.01.2019 |
| MODERNA, INC. | Corporate Officer/Principal | - |
Moderne Capital LLC
 Moderne Capital LLC Investment ManagersFinance Moderne Ventures invests in companies located in the United States with revenues of USD 1 - 30 million. The firm focuses across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Vorstandsvorsitzender | - |
Ausbildung von Axel Bouchon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderne Capital LLC
Moderne Capital LLC Investment ManagersFinance Moderne Ventures invests in companies located in the United States with revenues of USD 1 - 30 million. The firm focuses across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Finance |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Brii Biosciences Ltd. (China)
 Brii Biosciences Ltd. (China) BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Brain Games Corp.
Brain Games Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in neuroscience and tech to help people track and boost their happiness | Commercial Services |
BrainLuxury, Inc.
BrainLuxury, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures and commercializes nutritional brain supplements products | Health Technology |
AMLOne UG (haftungsbeschränkt) | |
Matter Neuroscience
Matter Neuroscience Packaged SoftwareTechnology Services Develops mobile application for neurological reward systems | Technology Services |
